iPS Cells for Modelling and Treatment of Retinal Diseases

Author： Chen Fred K.   McLenachan Samuel   Edel Michael   Da Cruz Lyndon   Coffey Peter J.   Mackey David A.  

Publisher： MDPI

E-ISSN： 2077-0383|3|4|1511-1541

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.3, Iss.4, 2014-12, pp. : 1511-1541

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

iPS Cells—The Triumphs and Tribulations

By Sharma Riddhi  

Dentistry Journal, Vol. 4, Iss. 2, 2016-06 ,pp. : 19-19

MDPI

Access to resources Recommend Favorite

Using iPS Cells toward the Understanding of Parkinson’s Disease

By Torrent Roger   De Angelis Rigotti Francesca   Dell’Era Patrizia   Memo Maurizio   Raya Angel   Consiglio Antonella  

Journal of Clinical Medicine, Vol. 4, Iss. 4, 2015-03 ,pp. : 548-566

MDPI

Access to resources Recommend Favorite

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy

By Roca Isart   Requena Jordi   Edel Michael J.   Alvarez-Palomo Ana Belén  

Journal of Clinical Medicine, Vol. 4, Iss. 2, 2015-01 ,pp. : 243-259

MDPI

Access to resources Recommend Favorite

Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential

By Ishii Tetsuya  

Journal of Clinical Medicine, Vol. 3, Iss. 4, 2014-10 ,pp. : 1064-1083

MDPI

Access to resources Recommend Favorite

Vitamin A Derivatives as Treatment Options for Retinal Degenerative Diseases

By Perusek Lindsay   Maeda Tadao  

Nutrients, Vol. 5, Iss. 7, 2013-07 ,pp. : 2646-2666

MDPI

Access to resources Recommend Favorite